Paysign sees over $1.5 million in stock sales by Topline Capital By Investing.com
Topline Capital Management, LLC, along with its managing member Collin McBirney, disclosed significant stock sales in Paysign, Inc. (NASDAQ:PAYS) according to recent SEC filings. The company, which has shown strong revenue growth of 27.75% over the last twelve months and maintains a healthy gross profit margin of 53.37%, is currently trading below its InvestingPro Fair Value. From December 27 to December 31, the firm sold a total of 479,105 shares of Paysign common stock, amounting to approximately $1,525,503. The shares were sold at prices ranging from $3.03 to $3.31 per share. Following these transactions, the firm retains ownership of 5,611,128 shares. These transactions were conducted by Topline Capital Partners (WA:CPAP), LP, a Delaware limited partnership, with Topline Capital Management acting as the investment manager and general partner. InvestingPro analysis reveals 7 additional key insights about PAYS, available in the comprehensive Pro Research Report, which helps investors make informed decisions through expert analysis of 1,400+ top stocks.
In other recent news, Paysign, Inc. has reported a 23% increase in revenue to $15.3 million during its latest earnings call, along with a 20.6% rise in adjusted EBITDA to $2.8 million. The company has also announced plans to expand its program offerings and a partnership with a leading pharmaceutical company. Despite facing challenges in its plasma business and ongoing investments, Paysign has projected revenues between $56.5 million and $58.5 million for the remainder of the year, with a net income guidance of $3 million to $3.5 million.
Furthermore, Paysign's patient affordability segment has seen a substantial surge, with an increase by 219% and 66 active programs. The company also reported a growth of 3.4% in plasma donor compensation revenue to $11.4 million. Gross margins have improved, reaching 55.5%.
In addition, Paysign anticipates a year-over-year revenue growth of 20% to 24% and projects gross profit margins at 54% to 55%. The company's operating expenses are expected to fall between $30 million and $32 million. These recent developments reflect Paysign's ongoing commitment to growth and financial stability.